tradmap

ESTA Establishment Labs Holdings Inc.

$61.07 -2.14%

Data as of close

Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Establishment Labs Holdings Inc. (ESTA) is a healthcare company in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, with a market capitalization of $1.8 billion. Shares last traded at $61.07, 37.2% below their 52-week high. Over the past year the stock is up 20.1%. Net profit margin is -15.8%, below the peer median of 5.3%. Revenue grew 27.1% year over year.

Market Cap
$1.8B
Shares Out
29.8M
EPS (TTM)
-$1.29
P/E (TTM)*
—
P/S Ratio
7.40
P/B Ratio
84.23
Dividend / Share
—
Dividend Yield
—
52-Week High
$97.26
52-Week Low
$47.00
Volume (venue)
53,847
Avg Vol (3m, venue)
30,440.365

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-6.99%
1M
-4.67%
3M
-35.41%
6M
-13.04%
YTD
-16.18%
1Y
+20.10%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
42.48
SMA (50)
$66.83
SMA (200)
$72.35
Price vs SMA50
-8.62%
Price vs SMA200
-15.60%
ATR (14)
$4.44

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$246M
Net Income
-$39M
Gross Margin
70.5%
Operating Margin
-7.6%
Net Margin
-15.8%
Return on Equity
-180.0%
Return on Assets
-11.1%
Current Ratio
3.84
Debt / Equity
12.11
Revenue Growth (YoY)
+27.1%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 -$0.39 2026-08-07
Q1 2026 -$0.45 2026-05-08
Q4 2025 (derived) -$0.07 2026-02-27
FY 2025 -$1.72 2026-02-27
Q3 2025 -$0.38 2025-11-07
Q2 2025 -$0.57 2025-08-07

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Orthopedic, Prosthetic & Surgical Appliances & Supplies peers

ESTA vs 14 industry peers (Orthopedic, Prosthetic & Surgical Appliances & Supplies), by market cap. Data as of close

P/S vs peers
7.40 / 2.67 med
+177% premium
Net margin vs peers
-15.8% / 5.3% med
below median
1–14 of 14
ISRGIntuitive Surgical$151.5B51.2313.0825.5%+1.13%
EWEdwards Lifesciences$53.7B53.498.2515.4%+1.35%
STESteris$22.7B28.253.7713.3%+2.70%
ZBHZimmer Biomet$18.6B23.012.189.5%+2.98%
ALGNAlign Technology$11.0B26.482.6510.0%+2.86%
MSAMsa Safety Inc$7.2B22.983.7116.1%+4.76%
ESTAEstablishment Labs Holdings Inc.$1.8B—7.40-15.8%-2.14%
CDRECadre Holdings, Inc.$1.4B37.461.975.3%+4.02%
ENOVEnovis Corp$1.2B—0.52-48.0%+3.51%
AVRAnteris Technologies Global Corp.$562M—250.82—-8.63%
SMTISanara MedTech Inc.$296M—2.69-29.2%-1.98%
INGNInogen Inc$182M—0.60-8.1%+0.00%
LAKELAKELAND INDUSTRIES INC$89M—0.47-14.0%+1.24%
NTRBNutriBand Inc.$77M———+1.04%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.